Showing results (1371-1380 of 2,471) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|July 24, 2018
Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?Florence Lefranc, Emilie Le Rhun, Robert Kiss, et al.Cancer Treatment Reviews|June 11, 2018
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversiesFrancesco Massari, Matteo Santoni, Vincenzo di Nunno, et al.Cancer Treatment Reviews|August 8, 2018
Personalizing aromatase inhibitor therapy in patients with breast cancerIssam S Hamadeh, Jai N Patel, Stephanie Rusin, et al.Cancer Treatment Reviews|July 28, 2018
The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenariosNicola Normanno, Andres Cervantes, Fortunato Ciardiello, et al.Cancer Treatment Reviews|July 28, 2018
Quality assessment of cancer cachexia clinical practice guidelinesWang-Qin Shen, Liang Yao, Xiao-Qin Wang, et al.Cancer Treatment Reviews|October 29, 2021
KRAS Inhibitors- yes but what next? Direct targeting of KRAS- vaccines, adoptive T cell therapy and beyondMisako Nagasaka, Bindu Potugari, Alexis Nguyen, et al.Cancer Treatment Reviews|October 16, 2021
De-escalation of axillary irradiation for early breast cancer - Has the time come?Elżbieta Senkus, Maria Joao Cardoso, Orit Kaidar-Person, et al.Cancer Treatment Reviews|September 26, 2021
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosisC Ciccarese, R Iacovelli, C Porta, et al.Cancer Treatment Reviews|February 18, 2022
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectivesGiorgio Patelli, Annalisa Zeppellini, Francesco Spina, et al.Cancer Treatment Reviews|February 8, 2022
Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysisAaron C Tan, Sze Huey Tan, Siqin Zhou, et al.Pageof 248